While adiponectin-deficient mice developed hepatic insulin resistance [16], administrating adiponectin or upregulating its plasma concentrations substantially improved insulin sensitivity in the liver and skeletal muscle of animals or humans [11, 14]. The gene discussed is ADIPOQ; the disease is Insulin resistance.